Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Bayer forgot to tell risks of heart surgery drug

According to the German drug giant Bayer AG, the reason the company failed to inform U.S. regulators about a study on the risks of the heart-surgery drug Trasylol was a mistake.

2 Oct 2006

Report says FDA not up to scratch

According to a new report by the Institute of Medicine (IOM), despite the debacle following the drug Vioxx which was withdrawn from the market two years ago, few lessons have been learned and the Food and Drug Administration (FDA) in the U.S. still lacks the power and resources to adequately monitor the safety of newly-approved drugs.

25 Sep 2006

Researchers create roadmap to integrin activation

Calling it an important technical advance in the study of the complex receptors and pathways of the body's cellular system, researchers at the University of California, San Diego (UCSD) School of Medicine have reconstructed the signaling pathways that impact activation of a receptor that is critical to the control of bleeding and to the thrombosis that occurs in heart attacks and strokes.

18 Sep 2006

Latest studies reveal more risks with Vioxx

Two major studies by experts in the U.S. and Australia have provided new evidence of the cardiovascular and kidney risks attached to both COX-2 inhibitors and NSAID painkillers.

18 Sep 2006

Are we getting enough vitamin D?

Scientists from the University of Ulster are to explore if we are getting enough vitamin D - vital for the formation of healthy bones and which may also help prevent diseases such as diabetes, cancers, rheumatoid arthritis and multiple sclerosis.

13 Sep 2006

Nitric oxide in blood and side-effects of painkillers

Cardiff University researchers have increased the understanding of why some painkillers increase the risk of heart attack and stroke.

12 Sep 2006

Drug infliximab may help ease ulcerative colitis

In good news for patients with stubborn cases of ulcerative colitis, a serious intestinal disorder, a new research review suggests that the drug infliximab can be a useful alternative if other treatments don't work.

12 Sep 2006

NIH launches "Knockout Mouse Project"

The National Institutes of Health (NIH) today awarded a set of cooperative agreements, totaling up to $52 million over five years, to launch the Knockout Mouse Project.

7 Sep 2006

FDA asks U.S. Marshals to seize dietary supplements

At the request of the U.S. Food and Drug Administration (FDA), on September 5, 2006, U.S. Marshals seized quantities of Ellagimax capsules, Coral Max capsules, Coral Max without Iron capsules, and Advanced Arthritis Support capsules distributed by Advantage Nutraceuticals L.L.C. of Fort Walton Beach, Florida, valued at approximately $55,000.00.

6 Sep 2006

Rheumatoid arthritis drugs appear to work better when delivered into the central nervous system

Rheumatoid arthritis drugs work better, at least in arthritic rats, when delivered into the central nervous system, Gary Firestein and colleagues (University of California San Diego) now report in the international open-access medical journal PLoS Medicine.

4 Sep 2006

New hope for patients with lung and joint disease

People who suffer from inflammatory conditions such as chronic diseases of the lung, joints and other organs could benefit from a new discovery by scientists at the University of Edinburgh.

4 Sep 2006

Bipolar disorder costs twice as much in lost productivity as major depressive disorder

Bipolar disorder costs twice as much in lost productivity as major depressive disorder, a study funded by the National Institutes of Health's (NIH) National Institute of Mental Health (NIMH) has found. Each U.S. worker with bipolar disorder averaged 65.5 lost workdays in a year, compared to 27.2 for major depression.

4 Sep 2006